Cue Biopharma, Inc. (CUE) Business Update Call (Transcript)
Source: SeekingAlpha
2025-04-15 18:12:03 ET
Cue Biopharma, Inc. (CUE)
Business Update Call
April 15, 2025 04:30 PM ET
Company Participants
Eric Ribner - LifeSci Advisors
Dan Passeri - Chief Executive Officer
Lucinda Warren - Chief Business Officer
Presentation
Operator
Good day, and welcome to the Cue Biopharma Business Update Call. All participants are in a listen-only mode.
I would now like to turn over to Eric Ribner from LifeSci Advisors. Please go ahead, Mr. Ribner....
Read the full article on Seeking Alpha
For further details see:
Cue Biopharma, Inc. (CUE) Business Update Call (Transcript)
Cue Biopharma Inc.
NASDAQ: CUE
CUE Trading
-7.89% G/L:
$0.2847 Last:
620,800 Volume:
$0.298 Open:
CUE Latest News
March 09, 2026 08:00:00 am
Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026
February 17, 2026 08:00:00 am
Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases
February 12, 2026 08:00:00 am
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer
CUE Stock Data
$30,117,989
80,549,371
0.16%
23
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
